Geode Capital Management’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Geode Capital Management’s Portfolio LHDX Stock Details LHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-95,621	Closed	-$10K	–	4886
2022 Q4	$10K	Hold	95,621	–	–	﹤0.01%	4843
2022 Q3	$101K	Hold	95,621	–	–	﹤0.01%	4574
2022 Q2	$177K	Buy	95,621 +3,545	+4%	+$8.62K	﹤0.01%	4347
2022 Q1	$328K	Sell	92,076 -1,360	-1%	-$6.68K	﹤0.01%	4145
2021 Q4	$804K	Buy	93,436 +9,349	+11%	+$59.5K	﹤0.01%	3814
2021 Q3	$639K	Sell	84,087 -10,586	-11%	-$89.3K	﹤0.01%	3913
2021 Q2	$628K	Sell	94,673 -63,392	-40%	-$400K	﹤0.01%	3831
2021 Q1	$1.91M	Buy	+158,065	New	+$3.14M	﹤0.01%	3272

Other funds holding LHDX

Eclipse Ventures Palo Alto, California $2.57B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Resolute Advisors San Francisco, California $417M AUM 60.99% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Geode Capital Management's LHDX Position: Q1 2023 in Review

Geode Capital Management sold out of Lucira Health, Inc. Common Stock (LHDX) in Q1 2023, closing a stake of 95,621 shares — an estimated $10K sold.

Geode Capital Management first reported a position in LHDX in Q1 2021 and held it in 8 quarters. The position peaked at $1.91M in Q1 2021. 6 funds tracked by Wall St. Rank hold LHDX as of Q1 2023.

Geode Capital Management reported no remaining Lucira Health, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Geode Capital Management sold 95,621 Lucira Health, Inc. Common Stock shares in Q1 2023, an estimated $10K.
Geode Capital Management first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Geode Capital Management's Lucira Health, Inc. Common Stock position peaked at $1.91M in Q1 2021.
6 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q1 2023.

Based on Geode Capital Management's 13F filing for Q1 2023, filed 15 May 2023.